Evidence map›Paper›PMID 30005943›Full record

ArticleJournal of chromatography. A2018

Magnetic beads-based neuraminidase enzyme microreactor as a drug discovery tool for screening inhibitors from compound libraries and fishing ligands from natural products.

Yu-Mei Zhao, Lv-Huan Wang, Si-Fan Luo, Qi-Qin Wang, Ruin Moaddel, Ting-Ting Zhang, Zheng-Jin Jiang

Open access · greenAbstract read
In one paragraph

Article in Journal of chromatography. A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Inhibition of sialidase activity as a therapeutic approach.Drug design, development and therapy · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yu-Mei ZhaoInstitute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, China.
Lv-Huan WangInstitute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, China.
Si-Fan LuoInstitute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, China.
Qi-Qin WangInstitute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, China; Department of Pharmacy and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine & New Drug Research, Jinan University, Guangzhou 510632, China.
Ruin MoaddelBiomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, United States.
Ting-Ting ZhangInstitute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, China. Electronic address: tzhtt008@jnu.edu.cn.
Zheng-Jin JiangInstitute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, China; Department of Pharmacy and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine & New Drug Research, Jinan University, Guangzhou 510632, China. Electronic address: jzjjackson@hotmail.com.
Jinan University · CNNational Institutes of Health · US

Funding

Immobilized Receptors In Drug DiscoveryZIAAG000295 · NIA · NATIONAL INSTITUTE ON AGING · PI EGAN, JOSEPHINE · 2009 to 2025
$11.4M
Intramural NIH HHS Z99 AG999999
6 · The paper itself

Abstract

Neuraminidase (NA) is a glycoside hydrolase that has been proposed as a potential therapeutic target for influenza. Thus, the identification of compounds that modulate NA activity could be of great therapeutic importance. The aim of this study is to develop a drug discovery tool for the identification of novel modulators of NA from both compound libraries and natural plant extracts. NA was immobilized onto the surface of magnetic beads and the inherent catalytic activity of NA-functionalized magnetic beads was characterized. Based on the enzymatic activity (hydrolysis ratio), the inhibitory activities of 12 compounds from plant secondary metabolites were screened, and the desired anti-NA activities of flavonoids were certified. Ligand fishing with the immobilized enzyme was optimized using an artificial test mixture consisting of oseltamivir, lycorine and matrine prior to carrying out the proof-of-concept experiment with the crude extract of Flos Lonicerae. The combination of ligand fishing and HPLC-MS/MS identified luteolin-7-O-β-D-glucoside, luteolin, 3,5-di-O-caffeoylquinic acid and 3,4-di-O-caffeoylquinic acid as neuraminidase inhibitory ligands in Flos Lonicerae. This is the first report on the use of neuraminidase functionalized magnetic beads for the identification of active ligands from a botanical matrix, and it sets the basis for the de novo identification of NA modulators from complex biological mixtures.

Indexed as

Drug DiscoveryDrug Evaluation, PreclinicalMagneticsMicrospheresSmall Molecule LibrariesBiological ProductsChromatography, High Pressure LiquidEnzyme InhibitorsImage Processing, Computer-AssistedKineticsLigandsLoniceraNeuraminidasePlant ExtractsReproducibility of ResultsTandem Mass SpectrometryBiological ProductsEnzyme InhibitorsLigandslonicerae flosNeuraminidasePlant ExtractsSmall Molecule LibrariesEnzyme immobilizationMagnetic beadsNeuraminidaseScreening inhibitors

Identifiers

PMID30005943
PMCPMC6261295
OpenAlexW2838232840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.